IL327445A - חיסון נגיף קורונה עם סוכר נמוך ושיטות שלו - Google Patents

חיסון נגיף קורונה עם סוכר נמוך ושיטות שלו

Info

Publication number
IL327445A
IL327445A IL327445A IL32744526A IL327445A IL 327445 A IL327445 A IL 327445A IL 327445 A IL327445 A IL 327445A IL 32744526 A IL32744526 A IL 32744526A IL 327445 A IL327445 A IL 327445A
Authority
IL
Israel
Prior art keywords
sugar
methods
low
coronavirus vaccine
coronavirus
Prior art date
Application number
IL327445A
Other languages
English (en)
Inventor
Jeng Shin Lee
Chung-Yi Wu
Chi-Huey Wong
Original Assignee
Rock Biomedical Inc
Jeng Shin Lee
Wu Chung Yi
Wong Chi Huey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2024/023597 external-priority patent/WO2024215616A2/en
Application filed by Rock Biomedical Inc, Jeng Shin Lee, Wu Chung Yi, Wong Chi Huey filed Critical Rock Biomedical Inc
Publication of IL327445A publication Critical patent/IL327445A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5123Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/64Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645Dendrimers; Multiple antigen peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL327445A 2023-10-09 2024-10-08 חיסון נגיף קורונה עם סוכר נמוך ושיטות שלו IL327445A (he)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202363588932P 2023-10-09 2023-10-09
US202463549343P 2024-02-02 2024-02-02
US202463575093P 2024-04-05 2024-04-05
PCT/US2024/023597 WO2024215616A2 (en) 2023-04-08 2024-04-08 Methods and compositions for dendritic cell targeting vaccines
PCT/US2024/050353 WO2025080565A1 (en) 2023-10-09 2024-10-08 Low-sugar coronavirus vaccine and methods thereof

Publications (1)

Publication Number Publication Date
IL327445A true IL327445A (he) 2026-05-01

Family

ID=95396272

Family Applications (1)

Application Number Title Priority Date Filing Date
IL327445A IL327445A (he) 2023-10-09 2024-10-08 חיסון נגיף קורונה עם סוכר נמוך ושיטות שלו

Country Status (4)

Country Link
AU (1) AU2024359608A1 (he)
IL (1) IL327445A (he)
TW (1) TW202517670A (he)
WO (1) WO2025080565A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120923537A (zh) * 2025-07-30 2025-11-11 天津大学 一种铁死亡抑制型类磷脂材料及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230016193A (ko) * 2020-05-20 2023-02-01 알렉산드루 아드리안 헨리히 베타코로나바이러스에 대한 면역화를 위한 바이러스 백신 벡터

Also Published As

Publication number Publication date
TW202517670A (zh) 2025-05-01
WO2025080565A1 (en) 2025-04-17
AU2024359608A1 (en) 2026-04-16

Similar Documents

Publication Publication Date Title
EP4135847A4 (en) Coronavirus vaccine
EP4117725A4 (en) CORONAVIRUS VACCINE METHODS AND COMPOSITIONS
EP4114460A4 (en) Vaccines against sars-cov-2 and other coronaviruses
GB2594365B (en) Coronavirus vaccine
IL284640A (he) מעכבי pcsk9 ושיטות לשימוש בהם
ZA202210641B (en) Coronavirus vaccine
EP4164687A4 (en) IMPROVED CORONAVIRUS VACCINE
IL284661A (he) מעכבי pcsk9 ושיטות לשימוש בהם
EP4313143A4 (en) Coronavirus vaccine formulations
EP4240436A4 (en) SCAFFOLDING AND TISSUE CONSTRUCTIONS
GB202217951D0 (en) Coronavirus vaccine
IL288310A (he) מודולטורים של cot ושיטות לשימוש בהם
IL297070A (he) חיסון נגד נגיף הקורונה
EP4376883A4 (en) RNA VACCINES
EP4440613A4 (en) CORONAVIRUS VACCINE FORMULATIONS
IL311855A (he) תכשירי lnp אימונוגניים ושיטותיהם
IL304401A (he) איגור תאים דמוי-בלאסטוציסט ושיטות
EP4159234A4 (en) VACCINE AGAINST SARS-COV-2
GB2620028B8 (en) Coronavirus vaccine
EP4228546C0 (en) SPLIT DENTURE
EP4230741A4 (en) Beta coronavirus cold acclimatized strain and vaccine
IL286492A (he) סוכריד עמיד בפני סיאלידה ואופן ייצור ושימוש אותו
EP4159853A4 (en) GENOME EDITING SYSTEM AND METHOD
IL285611A (he) מערכת חיסון קרקע מבוססת מיקרו-אצות ושיטות לשימוש
EP4031169A4 (en) Bee vaccines and methods of use